In this webinar, members of the Elegen team will discuss improvements they have made to enable the cell-free synthesis of ENFINIA™ DNA constructs that include a diverse range of complexities commonly used in the design and development of cell and gene therapies, including ITRs, LTRs, GC-rich promoters, hairpins, long homopolymers, short and long repeat regions, and regions with high or low GC content.